Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reverse cholesterol transport enhancement
- Molecular classification
- Other (Metabolic pathway; not a specific molecular entity)
01
Overview
Reverse cholesterol transport enhancement is not a specific molecule or receptor, but rather describes the process or therapeutic strategy aimed at increasing the body's capacity to remove excess cholesterol from peripheral tissues and deliver it to the liver for excretion[1][3][4][5]. This is considered a mechanism or pathway rather than a single biological entity, and thus does not map directly onto established molecular targets such as receptors or enzymes.
- Other names
- Reverse cholesterol transportRCTHDL-mediated cholesterol effluxcholesterol efflux pathway
02
Mechanism of action
Increase HDL formation and function (via ApoA1 or SR-B1); Enhance cholesterol efflux from macrophages (via ABCA1/ABCG1 activation); Inhibit cholesteryl ester transfer protein (CETP) to boost HDL levels; Inhibit miR-33 to upregulate ABCA1/ABCG1
03
Biological functions
Cholesterol homeostasisLipid transportCardiovascular protectionRemoval of cellular cholesterol
04
Disease associations
Cardiovascular disease (atherosclerosis)Metabolic syndrome
05
Safety considerations
Previous clinical failures of CETP inhibitors due to off-target effects, lack of efficacy, and increased morbidityPotential for modulation of hepatic triglyceride and fatty acid metabolism via miR-33 inhibition, leading to metabolic disturbancesUncertainties in linking HDL cholesterol levels directly to cardiovascular risk reduction
06
Interacting drugs
niacin
5 more in the full profile.
07
Biomarkers
HDL cholesterol (HDL-C, imperfect proxy)Cholesterol efflux capacity (CEC; functional assay of serum ability to extract cholesterol from macrophages)
Beyond the preview
Go deeper on Reverse cholesterol transport enhancement.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reverse cholesterol transport enhancement.